FDA Inspection
AlloSource Inc.AlloSource Inc. – FDA Inspection, Dec 23, 2009
Record Details
This FDA Inspection record concerns AlloSource Inc., with an inspection on December 23, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- AlloSource Inc.
- Inspection Date
- December 23, 2009
- Product Type
- Biologics
View Company Profile
ID · aebdc66e-0a28-4a95-b798-4ab5a4fe74eb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 635821
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.180(a)Procedures to meet core CTGP
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AlloSource Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 23, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 23, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 14, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for AlloSource Inc.
- FDA Inspection 1267396 - 2025-03-27
- FDA Inspection 1062115 - 2018-07-23
- FDA Inspection 944122 - 2015-09-23
- FDA Inspection 796666 - 2012-08-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.